期刊文献+

血清胱抑素C在慢性心力衰竭患者心功能评价中的应用 被引量:7

The application of serum Cystatin C level in evaluation of cardiac function in patients with chronic heart failure
暂未订购
导出
摘要 目的:探讨血清胱抑素C(Cys C)水平的变化对慢性心力衰竭(CHF)患者临床心功能变化评价的临床意义。方法:选取CHF组80例,健康体检正常者(对照组)30名。心力衰竭程度按纽约心脏病协会心功能分级法,采用免疫比浊法测定各组血清Cys C水平,并采用超声心动图测定左心室射血分数及左心室舒张末内径评价患者左心室功能,同时记录住院期间及出院6个月内患者的病死率和因CHF再次发作住院率。结果:CHF组患者血清Cys C水平显著高于对照组(P<0.01),且随着心功能分级的增高,血清Cys C水平也逐渐升高(P<0.01)。患者血清Cys C水平与左心室舒张末内径呈正相关关系(P<0.05),与左心室射血分数呈负相关关系(P<0.05)。高、低血清Cys C组中患者住院期间病死率差异无统计学意义(P>0.05),高血清Cys C组出院6个月病死率及因心力衰竭再住院率均升高(P<0.05)。结论:Cys C对于评价CHF患者临床心功能变化及评估预后具有一定意义。 Objective:To observe the change of serum Cystatin C (Cys C) level in patients with chronic heart failure(CHF), and investigate the significance between Cys C level and cardiac function. Methods:The subjects were divided into CHF group(n = 80) and normal control group (n = 30). Severity of CHF was according to New York Heat Association (NYHA) heart functional classes. Serum Cyst C level was measured by ELISA assay. The left ventricular ejection fraction and left ventricular end diastolic diameter were detected by ultrasonic cardiogram. The mortality and re-hospitalization for chronic heart failure were recorded during hospitalization and discharge from hospital within 6 months. Results: The level of serum Cys C in CHF group was higher than that in control group ( P 〈 0.01 ) , it was increased with the higher class of NYHA heart functional classification( P 〈 0.01 ). Serum Cys C level had negatively correlated with left ventricular ejection fraction, but positively correlated with left ventricular end diastolic diameter( P 〈 0.05 ). There was no statistical difference of the mortality between higher CysC level group and lower Cys C level group (P 〉 O. 05 ). During following-up for 6 months, the re-hospitalization for chronic heart failure and fatality were higher in patients with higher Cys C level than in those with lower Cys C level( P 〈 0.05 ). Conclusions'.. Serum Cys C level is a potential biomarker for diagnosis of chronic heart failure, and it can reflect the recent prognosis of chronic heart failure.
作者 赵甫 黄涛
出处 《蚌埠医学院学报》 CAS 2014年第3期324-325,328,共3页 Journal of Bengbu Medical College
关键词 心力衰竭 胱抑素C 预后 heart failure Cystatin C prognosis
  • 相关文献

参考文献8

  • 1Suzuki Y, Matsushita K,Yoshida T, et al. Clinical validity of renal funciion markers including serum cystatin C on chronic kidney disease classification [ J]. Rinsho Byori ,2011,59 (4) :345 - 351.
  • 2张新超.心力衰竭治疗的若干进展[J].世界急危重病医学杂志,2005,2(4):822-827. 被引量:10
  • 3刘亚斌.胱抑素c与心血管病相关性的研究进展[J].心血管病进展,2010,31(6):864-868.
  • 4Taglieri N, Koenig W, Kaski JC, et al. Cystatin C and cardiovascular risk[ J]. Clin Chem,2009,55 ( 11 ) : 1932 - 1943.
  • 5Lutgens SP, Cieutjens KB, Daemen M.I, et al. Cathepsin cysteine proteases in cardiovascular disease [ J ]. FASEB J, 2007,21 ( 12 ) : 3029 - 3041.
  • 6Samak MJ, Katz R, Stehman Breen CO, et al. Cystatin C concentration as a risk factor for heart failure in older adults[J]. Ann Intern Med,2005,142 (7) :497 - 505.
  • 7Patel PC, Ayers CR, Murphy SA, et al. Association of cystatin C with left ventricular structure and function:the dallas heart study [ J]. Circ Heart Fail,2009,2(2) :98 - 104.
  • 8Ix JH, Shlipak MG, Chertow GM, et al. Cystatin C, left ventricular hypertrophy, and diastolic dysfunction: data from the Heart and Soul Study[J]. J Card Fail,2006,12(8) :601 -607.

共引文献9

同被引文献89

  • 1孙建琦,胡宇宁,汪靖,章锡林,胡剑平.胱抑素C与原发性高血压患者室壁厚度及心功能不全的相关性[J].安徽医学,2013,34(10):1478-1480. 被引量:11
  • 2向礼贤.血清胱抑素C检测与疾病[J].四川医学,2004,25(11):1258-1259. 被引量:31
  • 3张建军.血清胱抑素与妊娠高血压疾病临床观察[J].医学研究杂志,2006,35(12):64-65. 被引量:3
  • 4谈俊,臧敏华.高血压病左室肥厚患者血浆脑钠肽的变化[J].实用诊断与治疗杂志,2007,21(11):835-837. 被引量:4
  • 5Suzuki Y,Matsushita K,Yoshida T,et al.Clinical validity of renal func- tion markers including serum cystatin C on chronic kidney disease classi- fication[J].Rinsho Byori,2011,59(4):345-351.
  • 6Royakkers AA,Korevaar JC,van Suijlen JD,et al.Serum and urine cys- tatin C are poor biomarkers for acute kidney injury and renal replacement therapy[J].Intensive Care Med,2011,37(3):493-501.
  • 7Hao M,Guo D,Jaber BL,et al.Transforming growth factor-beta I gene polymorphisms and cardiovascular disease in hemodialysis patients [J]. Kidney Int,2004,66(1):419-427.
  • 8Sukhova GK,Wang B,Libby P,et al.Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice[J]. Circ Res,2005(96(3):368-375.
  • 9Ge C,Ren F,Lu S,et al.Clinical prognostic significance of plasma cystatin C levels among patients with acute coronary syndrome [J].Clin Cardiol, 2009,32(11):644-648.
  • 10Imai A,Komatsu S,Ohara T,et al.Serum cystatin C is associated with early stage coronary atherosclerotic plaque morphology on multidetector computed tomography[J].Atherosclerosis,2011,218(2):350-355.

引证文献7

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部